Citadel Advisors - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260901. A total of 1 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q2 2016$20,000
-42.9%
10,000
+122.2%
0.00%
Q4 2015$35,000
+218.2%
4,500
+125.0%
0.00%
Q3 2015$11,000
-76.6%
2,000
-61.5%
0.00%
Q2 2015$47,000
-9.6%
5,200
-37.3%
0.00%
Q1 2015$52,000
+173.7%
8,300
+151.5%
0.00%
Q4 2014$19,0003,3000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2016
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 208$00.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders